On your mark, get set, go! Biosimilar litigation takes off in Canada30 May 2012Marcus KleeOn May 18, 2012, Amgen Canada Inc. and Amgen Inc. (“Amgen”) commenced a proceeding (Court File No. T-989-12) under the Patented Medicines...Read More
